Skip to content
2000
Volume 32, Issue 12
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Apitherapy, the therapeutic use of bee products, has attracted attention for its potential in treating various ailments. Honey is unique among bee products because it has a high concentration of medicinal chemicals. In recent years, there has been growing concern about exploring the neuroprotective features of honey. Our article aimed to consolidate existing research on the neuroprotective potential of honey, shedding more focus on its mechanisms of action and therapeutic properties. The literature suggests that honey exhibits neuroprotective properties by attenuating oxidative stress, alleviating neuroinflammation, and enhancing neuronal survival and regeneration. Especially, honey’s potential to mitigate neurodegenerative disorders and enhance cognitive function and memory. These reports position honey as a promising candidate for neuroprotection, offering a natural and accessible therapeutic option to combat neurological disorders. Its multifaceted mechanism of action makes it a valuable asset in neurotherapy. However, more research is warranted to clarify the specific compounds responsible for their neuroprotective effects and to optimize their therapeutic application. Unlocking the full potential of honey in neuroprotection could open the door to novel therapeutic approaches for the management of neurological conditions.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128383966250726122514
2025-08-13
2026-03-04

  • From This Site

    /content/journals/cpd/10.2174/0113816128383966250726122514
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AlmasaudiS. The antibacterial activities of honey.Saudi J. Biol. Sci.20212842188219610.1016/j.sjbs.2020.10.017 33911935
     [Google Scholar]
  2. MisraniA. TabassumS. YangL. Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease.Front. Aging Neurosci.20211361758810.3389/fnagi.2021.617588 33679375
     [Google Scholar]
  3. BejE. CesareP. VolpeA.R. d’AngeloM. CastelliV. Oxidative stress and neurodegeneration: Insights and therapeutic strategies for Parkinson’s disease.Neurol. Int.202416350251710.3390/neurolint16030037 38804477
     [Google Scholar]
  4. HilalB. KhanM.M. FariduddinQ. Recent advancements in deciphering the therapeutic properties of plant secondary metabolites: Phenolics, terpenes, and alkaloids.Plant Physiol. Biochem.202421110867410.1016/j.plaphy.2024.108674 38705044
     [Google Scholar]
  5. RahmanM.M. WangX. IslamM.R. Multifunctional role of natural products for the treatment of Parkinson’s disease: At a glance.Front. Pharmacol.20221397638510.3389/fphar.2022.976385 36299886
     [Google Scholar]
  6. DuboisB. VillainN. SchneiderL. Alzheimer disease as a clinical-biological construct—An International Working Group recommendation.JAMA Neurol.202481121304131110.1001/jamaneurol.2024.3770 39483064
     [Google Scholar]
  7. De PlanoL.M. SaittaA. OddoS. CaccamoA. Epigenetic changes in Alzheimer’s disease: DNA methylation and histone modification.Cells202413871910.3390/cells13080719 38667333
     [Google Scholar]
  8. StocchiF. BraviD. EmmiA. AntoniniA. Parkinson disease therapy: Current strategies and future research priorities.Nat. Rev. Neurol.2024201269570710.1038/s41582‑024‑01034‑x 39496848
     [Google Scholar]
  9. SimonD.K. TannerC.M. BrundinP. Parkinson disease epidemiology, pathology, genetics, and pathophysiology.Clin. Geriatr. Med.202036111210.1016/j.cger.2019.08.002 31733690
     [Google Scholar]
  10. NallsM.A. BlauwendraatC. VallergaC.L. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: A meta-analysis of genome-wide association studies.Lancet Neurol.201918121091110210.1016/S1474‑4422(19)30320‑5 31701892
     [Google Scholar]
  11. SivanandyP. LeeyT.C. XiangT.C. Systematic review on Parkinson’s disease medications, emphasizing on three recently approved drugs to control Parkinson’s symptoms.Int. J. Environ. Res. Public Health202119136410.3390/ijerph19010364 35010624
     [Google Scholar]
  12. OlasB. Honey and its phenolic compounds as an effective natural medicine for cardiovascular diseases in humans?Nutrients202012228310.3390/nu12020283 31973186
     [Google Scholar]
  13. ZhangY.Z. SiJ.J. LiS.S. Chemical analyses and antimicrobial activity of nine kinds of unifloral Chinese honeys compared to Manuka honey (12+ and 20+).Molecules2021269277810.3390/molecules26092778 34066799
     [Google Scholar]
  14. Rioux BilanA. FreyssinA. PageG. FauconneauB. Natural polyphenols effects on protein aggregates in Alzheimer’s and Parkinson’s prion-like diseases.Neural Regen. Res.201813695596110.4103/1673‑5374.233432 29926816
     [Google Scholar]
  15. GodoyL.D. LucasJ.E. BenderA.J. RomanickS.S. FergusonB.S. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.Mol. Nutr. Food Res.201761420160074410.1002/mnfr.201600744 27981795
     [Google Scholar]
  16. MaitipJ. PolgateA. PromsartW. Evaluation of stingless bee (Tetragonula pagdeni) honey properties and melissopalynological analysis from different geographical origins in Thailand.J. Ecol. Environ.2024481410.5141/jee.23.062
     [Google Scholar]
  17. Akyıldızİ.E. YetimoğluE.K. RadayS. Development of a novel pretreatment protocol for the efficient isolation and enrichment of honey proteome using pine honey and the hypopharyngeal glands of Apis mellifera L.J. Food Meas. Charact.20221642616262910.1007/s11694‑022‑01380‑8
     [Google Scholar]
  18. Eteraf-OskoueiT. NajafiM. Uses of natural honey in cancer: An updated review.Adv. Pharm. Bull.202112224826110.34172/apb.2022.026 35620330
     [Google Scholar]
  19. MichiuD. SocaciuM.I. FogarasiM. Implementation of an analytical method for spectrophotometric evaluation of total phenolic content in essential oils.Molecules2022274134510.3390/molecules27041345 35209133
     [Google Scholar]
  20. LawagI.L. LimL.Y. JoshiR. HammerK.A. LocherC. A comprehensive survey of phenolic constituents reported in Monofloral honeys around the globe.Foods2022118115210.3390/foods11081152 35454742
     [Google Scholar]
  21. AyoubWS Ritu ZahoorI. Exploiting the polyphenolic potential of honey in the prevention of chronic diseases.Food Chem Adv2023310037310.1016/j.focha.2023.100373
     [Google Scholar]
  22. BiesagaM. PyrzyńskaK. Stability of bioactive polyphenols from honey during different extraction methods.Food Chem.20131361465410.1016/j.foodchem.2012.07.095 23017391
     [Google Scholar]
  23. HossenM.S. AliM.Y. JahurulM.H.A. Abdel-DaimM.M. GanS.H. KhalilM.I. Beneficial roles of honey polyphenols against some human degenerative diseases: A review.Pharmacol. Rep.20176961194120510.1016/j.pharep.2017.07.002
     [Google Scholar]
  24. GoślińskiM. NowakD. SzwengielA. Multidimensional comparative analysis of bioactive phenolic compounds of honeys of various origin.Antioxidants202110453010.3390/antiox10040530 33805391
     [Google Scholar]
  25. IsmailN.I. Abdul KadirM.R. MahmoodN.H. SinghO.P. IqbalN. ZulkifliR.M. Apini and Meliponini foraging activities influence the phenolic content of different types of Malaysian honey.J. Apic. Res.201655213715010.1080/00218839.2016.1207388
     [Google Scholar]
  26. SuleimanM.H.A. ALaerjaniW.M.A. MohammedM.E.A. Influence of altitudinal variation on the total phenolic and flavonoid content of Acacia and Ziziphus honey.Int. J. Food Prop.20202312077208610.1080/10942912.2020.1842445
     [Google Scholar]
  27. NyarkoK. BoozerK. GreenliefC.M. Profiling of the polyphenol content of honey from different geographical origins in the United States.Molecules20232813501110.3390/molecules28135011 37446673
     [Google Scholar]
  28. PhamT.N. NguyenT.V. LeD.T. Phenolic profiles, antioxidant, antibacterial activities and nutritional value of vietnamese honey from different botanical and geographical sources.AgriEngineering2022441116113810.3390/agriengineering4040069
     [Google Scholar]
  29. ChikhaouiM. GalmanA. ToufikB. Total phenolic content in monofloral honey varieties from Beni Mellal-Khenifra, Central Morocco: variability and determinants.J Phytomed Ther20242321675167910.4314/jopat.v23i2.21
     [Google Scholar]
  30. KavanaghS. GunnooJ. Marques PassosT. StoutJ.C. WhiteB. Physicochemical properties and phenolic content of honey from different floral origins and from rural versus urban landscapes.Food Chem.2019272667510.1016/j.foodchem.2018.08.035 30309595
     [Google Scholar]
  31. ŠarićG. VahčićN. Bursać KovačevićD. PutnikP. The changes of flavonoids in honey during storage.Processes20208894310.3390/pr8080943
     [Google Scholar]
  32. GeorgeE.M. GannabathulaS. LakshithaR. LiuY. KantonoK. HamidN. Antibacterial properties, arabinogalactan proteins, and bioactivities of New Zealand honey.Antioxidants202514437510.3390/antiox14040375 40298625
     [Google Scholar]
  33. StephensJ.M. SchlothauerR.C. MorrisB.D. Phenolic compounds and methylglyoxal in some New Zealand manuka and kanuka honeys.Food Chem.20101201788610.1016/j.foodchem.2009.09.074
     [Google Scholar]
  34. DengJ. LiuR. LuQ. Biochemical properties, antibacterial and cellular antioxidant activities of buckwheat honey in comparison to manuka honey.Food Chem.201825224324910.1016/j.foodchem.2018.01.115 29478537
     [Google Scholar]
  35. KıvrakŞ. Kıvrakİ. Assessment of phenolic profile of Turkish honeys.Int. J. Food Prop.201720486487610.1080/10942912.2016.1188307
     [Google Scholar]
  36. PernaA. IntagliettaI. SimonettiA. GambacortaE. A comparative study on phenolic profile, vitamin C content and antioxidant activity of Italian honeys of different botanical origin.Int. J. Food Sci. Technol.20134891899190810.1111/ijfs.12169
     [Google Scholar]
  37. KečkešS. GašićU. VeličkovićT.Ć. Milojković-OpsenicaD. NatićM. TešićŽ. The determination of phenolic profiles of Serbian unifloral honeys using ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry.Food Chem.20131381324010.1016/j.foodchem.2012.10.025 23265452
     [Google Scholar]
  38. MartosI. FerreresF. YaoL. D’ArcyB. CaffinN. Tomás-BarberánF.A. Flavonoids in monospecific eucalyptus honeys from Australia.J. Agric. Food Chem.200048104744474810.1021/jf000277i 11052728
     [Google Scholar]
  39. SaranrajP. SivasakthiS. Comprehensive review on honey: Biochemical and medicinal properties.J. Acad. Ind. Res.2018610165178
     [Google Scholar]
  40. AhmedS. OthmanN.H. The anti-cancer effects of Tualang honey in modulating breast carcinogenesis: An experimental animal study.BMC Complement. Altern. Med.201717120810.1186/s12906‑017‑1721‑4 28399853
     [Google Scholar]
  41. OnifadeA.A. JewellA.P. AjadiT.A. RahamonS.K. OgunrinO.O. Effectiveness of a herbal remedy in six HIV patients in Nigeria.J. Herb. Med.2013339910310.1016/j.hermed.2013.04.006
     [Google Scholar]
  42. AnyanwuC.U. Investigation of in vitro antifungal activity of honey.J. Med. Plants Res.201261810.5897/JMPR12.577
     [Google Scholar]
  43. ErejuwaO.O. SulaimanS.A. Ab WahabM.S. Honey: A novel antioxidant.Molecules20121744400442310.3390/molecules17044400 22499188
     [Google Scholar]
  44. AlmasaudiS.B. AbbasA.T. Al-HindiR.R. Manuka honey exerts antioxidant and anti‐inflammatory activities that promote healing of acetic acid‐induced gastric ulcer in rats.Evid. Based Complement. Alternat. Med.2017201715413917710.1155/2017/5413917 28250794
     [Google Scholar]
  45. HassanM.I. MabroukG.M. ShehataH.H. AboelhusseinM.M. Antineoplastic effects of bee honey and Nigella sativa on hepatocellular carcinoma cells.Integr. Cancer Ther.201211435436310.1177/1534735410387422 21147814
     [Google Scholar]
  46. Tlak GajgerI. VlainićJ. Antioxidant activity of honey bee products.Antioxidants20251416410.3390/antiox14010064 39857398
     [Google Scholar]
  47. TabanQ. MumtazP.T. AliA. Honey in anticancer drug toxicity. In: Therapeutic Applications of Honey and its Phytochemicals.SingaporeSpringer202030732410.1007/978‑981‑15‑7305‑7_14
     [Google Scholar]
  48. NajafiM. Eteraf OskoueiT. RafieF. Mahdizadeh-AghdamE. Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury.J. Mol. Cell. Cardiol.200844479010.1016/j.yjmcc.2008.02.189
     [Google Scholar]
  49. KuropatnickiA.K. KłósekM. KucharzewskiM. Honey as medicine: Historical perspectives.J. Apic. Res.201857111311810.1080/00218839.2017.1411182
     [Google Scholar]
  50. WangX.H. AndraeL. EngesethN.J. Antimutagenic effect of various honeys and sugars against Trp-p-1.J. Agric. Food Chem.200250236923692810.1021/jf025641n 12405798
     [Google Scholar]
  51. AzimM.K. PerveenH. MesaikM.A. SimjeeS.U. Antinociceptive activity of natural honey in thermal‐nociception models in mice.Phytother. Res.200721219419710.1002/ptr.2049 17160970
     [Google Scholar]
  52. HannanA. MunirS. ArshadM.U. BashirN. In vitro antimycobacterial activity of Pakistani beri honey using BACTEC MGIT 960.Int. Sch. Res. Not20142014490589910.1155/2014/490589
     [Google Scholar]
  53. MumtazP.T. BashirS.M. RatherM.A. DarK.B. TabanQ. SajoodS. Antiproliferative and apoptotic activities of natural honey. In: Therapeutic Applications of Honey and its Phytochemicals.SingaporeSpringer202034536010.1007/978‑981‑15‑6799‑5_18
     [Google Scholar]
  54. KassimM MansorM AchouiM YanOS DeviS YusoffKM Honey as an immunomodulator during sepsis in animal model.Crit Care200913P40(Suppl. 4)10.1186/cc8096
     [Google Scholar]
  55. MohamedZ.B.H. Hamad AlfarisiH.A. Abdul WahabA.Y. Abd FuaatA. Che MohamadC.A. IbrahimM.B. Trihoney improves testicular weight change and histopathological alterations in hypercholesterolemic rabbits.Asia Pac. J. Mol. Biol. Biotechnol.2020283758710.35118/apjmbb.2020.028.3.08
     [Google Scholar]
  56. Bt Hj IdrusR. SainikN.Q.A.V. NordinA. SaimA.B. SulaimanN. Cardioprotective effects of honey and its constituent: An evidence-based review of laboratory studies and clinical trials.Int. J. Environ. Res. Public Health20201710361310.3390/ijerph17103613 32455701
     [Google Scholar]
  57. ErejuwaO.O. SulaimanS.A. Ab WahabM.S. SirajudeenK.N.S. SallehS. GurtuS. Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress.Oxid. Med. Cell. Longev.2012201211410.1155/2012/374037 22315654
     [Google Scholar]
  58. ZhaoH. ChengN. HeL. Hepatoprotective effects of the honey of Apis cerana Fabricius on bromobenzene‐induced liver damage in mice.J. Food Sci.201883250951610.1111/1750‑3841.14021 29337369
     [Google Scholar]
  59. GharzouliK. AmiraS. GharzouliA. KhennoufS. Gastroprotective effects of honey and glucose-fructose-sucrose-maltose mixture against ethanol-, indomethacin-, and acidified aspirin-induced lesions in the rat.Exp. Toxicol. Pathol.200254321722110.1078/0940‑2993‑00255 12484559
     [Google Scholar]
  60. AzmanK.F. ZakariaR. OthmanZ. Abdul AzizC.B. Neuroprotective effects of Tualang honey against oxidative stress and memory decline in young and aged rats exposed to noise stress.J. Taibah Univ. Sci.201812327328410.1080/16583655.2018.1465275
     [Google Scholar]
  61. IbrahimA. EldaimM.A.A. Abdel-DaimM.M. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats.Cytotechnology20166841039104810.1007/s10616‑015‑9860‑2 25720368
     [Google Scholar]
  62. El-HaskouryR. Al-WailiN. El-HilalyJ. Al-WailiW. LyoussiB. Antioxidant, hypoglycemic, and hepatoprotective effect of aqueous and ethyl acetate extract of carob honey in streptozotocin -induced diabetic rats.Vet. World201912121916192310.14202/vetworld.2019.1916‑1923 32095041
     [Google Scholar]
  63. MohamedM. SulaimanS.A. JaafarH. SirajudeenK.N.S. Antioxidant protective effect of honey in cigarette smoke-induced testicular damage in rats.Int. J. Mol. Sci.20111295508552110.3390/ijms12095508 22016605
     [Google Scholar]
  64. AsiyahH.A. Effects of nicotine and Gelam honey on testis parameters and sperm qualities of juvenile rats.Sci. Res. Essays201162610.5897/SRE10.1016
     [Google Scholar]
  65. ZaidS.S.M. SulaimanS.A. SirajudeenK.N.M. OthmanN.H. The effects of tualang honey on female reproductive organs, tibia bone and hormonal profile in ovariectomised rats - animal model for menopause.BMC Complement. Altern. Med.201010182210.1186/1472‑6882‑10‑82 21194469
     [Google Scholar]
  66. ZaidS.S.M. OthmanS. KassimN.M. Potential protective effect of Tualang honey on BPA-induced ovarian toxicity in prepubertal rat.BMC Complement. Altern. Med.2014141509910.1186/1472‑6882‑14‑509 25519484
     [Google Scholar]
  67. SalimS. Oxidative stress and the central nervous system.J. Pharmacol. Exp. Ther.2017360120120510.1124/jpet.116.237503 27754930
     [Google Scholar]
  68. VezzaniA. AronicaE. MazaratiA. PittmanQ.J. Epilepsy and brain inflammation.Exp. Neurol.2013244112110.1016/j.expneurol.2011.09.033 21985866
     [Google Scholar]
  69. KimSY BuckwalterM SoreqH VezzaniA KauferD Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis.Epilepsia201253s63744(Suppl. 6)10.1111/j.1528‑1167.2012.03701.x23134494
     [Google Scholar]
  70. SternbergE.M. Interactions between the immune and neuroendocrine systems.Prog Brain Res2000122354210.1016/S0079‑6123(08)62129‑9 10737049
     [Google Scholar]
  71. VezzaniA. BalossoS. RavizzaT. Inflammation and epilepsy.Handb. Clin. Neurol.201210716317510.1016/B978‑0‑444‑52898‑8.00010‑0 22938970
     [Google Scholar]
  72. CattaneoS. VerlengiaG. MarinoP. SimonatoM. BettegazziB. NPY and gene therapy for epilepsy: How, when, and Y.Front. Mol. Neurosci.20211360800110.3389/fnmol.2020.608001 33551745
     [Google Scholar]
  73. WuL.H. LinC. LinH.Y. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression.Mol. Neurobiol.20165321080109110.1007/s12035‑014‑9042‑9 25579382
     [Google Scholar]
  74. CopmansD. Orellana-PaucarA.M. SteursG. Methylated flavonoids as anti-seizure agents: Naringenin 4′,7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models.Neurochem. Int.201811212413310.1016/j.neuint.2017.11.011 29174382
     [Google Scholar]
  75. ArulselvanP. FardM.T. TanW.S. Role of antioxidants and natural products in inflammation.Oxid. Med. Cell. Longev.201620161527613010.1155/2016/5276130 27803762
     [Google Scholar]
  76. Al-HatamlehM.A.I. BoerJ.C. WilsonK.L. PlebanskiM. MohamudR. MustafaM.Z. Antioxidant-based medicinal properties of stingless bee products: Recent progress and future directions.Biomolecules202010692310.3390/biom10060923 32570769
     [Google Scholar]
  77. SousaJ.M.B. SouzaE.L. MarquesG. Sugar profile, physicochemical and sensory aspects of monofloral honeys produced by different stingless bee species in Brazilian semi-arid region.Lebensm. Wiss. Technol.20166564565110.1016/j.lwt.2015.08.058
     [Google Scholar]
  78. OliveiraR.G. JainS. LunaA.C. FreitasL.S. AraújoE.D. Screening for quality indicators and phenolic compounds of biotechnological interest in honey samples from six species of stingless bees (Hymenoptera: Apidae).Food Sci Technol201737455255710.1590/1678‑457x.25716
     [Google Scholar]
  79. Alvarez-SuarezJ.M. GiampieriF. BrencianiA. Apis mellifera vs Melipona beecheii Cuban polifloral honeys: A comparison based on their physicochemical parameters, chemical composition and biological properties.Lebensm. Wiss. Technol.20188727227910.1016/j.lwt.2017.08.079
     [Google Scholar]
  80. SouzaE.C.A. MenezesC. FlachA. Stingless bee honey (Hymenoptera, Apidae, Meliponini): A review of quality control, chemical profile, and biological potential.Apidologie202152111313210.1007/s13592‑020‑00802‑0
     [Google Scholar]
  81. KamaruzzamanM.A. ChinK.Y. Mohd RamliE.S. A review of potential beneficial effects of honey on bone health.Evid. Based Complement. Alternat. Med.2019201911010.1155/2019/8543618 31641368
     [Google Scholar]
  82. HongS.Y. JeongW.S. JunM. Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells.Molecules2012179108311084510.3390/molecules170910831 22964500
     [Google Scholar]
  83. SmelandO.B. HaderaM.G. McDonaldT.S. SonnewaldU. BorgesK. Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.J. Cereb. Blood Flow Metab.20133371090109710.1038/jcbfm.2013.54 23611869
     [Google Scholar]
  84. LagoaR. GrazianiI. Lopez-SanchezC. Garcia-MartinezV. Gutierrez-MerinoC. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria.Biochim. Biophys. Acta20111807121562157210.1016/j.bbabio.2011.09.022 22015496
     [Google Scholar]
  85. GibelliniL. BianchiniE. De BiasiS. NasiM. CossarizzaA. PintiM. Natural compounds modulating mitochondrial functions.Evid. Based Complement. Alternat. Med.2015201511310.1155/2015/527209 26167193
     [Google Scholar]
  86. Abrego-GuandiqueD.M. IloriO.A. CaroleoM.C. CannataroR. CioneE. TucciP. Differential digestive stability of food-derived microRNAs: The case of miR-30c-5p and miR-92a-3p in polyfloral honey.Curr. Issues Mol. Biol.20244677473748510.3390/cimb46070443 39057084
     [Google Scholar]
  87. Baranowska-WójcikE. SzwajgierD. Winiarska-MieczanA. Honey as the potential natural source of cholinesterase inhibitors in Alzheimer’s disease.Plant Foods Hum. Nutr.2020751303210.1007/s11130‑019‑00791‑1 31925635
     [Google Scholar]
  88. Sabogal-GuáquetaA.M. Muñoz-MancoJ.I. Ramírez-PinedaJ.R. Lamprea-RodriguezM. OsorioE. Cardona-GómezG.P. The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice.Neuropharmacology20159313414510.1016/j.neuropharm.2015.01.027 25666032
     [Google Scholar]
  89. FunakoshiT. KanzakiN. OtsukaY. IzumoT. ShibataH. MachidaS. Quercetin inhibits adipogenesis of muscle progenitor cells in vitro.Biochem. Biophys. Rep.201813394410.1016/j.bbrep.2017.12.003 29379887
     [Google Scholar]
  90. ZaplaticE. BuleM. ShahS.Z.A. UddinM.S. NiazK. Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer’s disease.Life Sci.201922410911910.1016/j.lfs.2019.03.055 30914316
     [Google Scholar]
  91. LiY. TianQ. LiZ. DangM. LinY. HouX. Activation of Nrf2 signaling by sitagliptin and quercetin combination against β‐amyloid induced Alzheimer’s disease in rats.Drug Dev. Res.201980683784510.1002/ddr.21567 31301179
     [Google Scholar]
  92. ParkK.S. ChongY. KimM.K. Myricetin: Biological activity related to human health.Appl Biol Chem201659225926910.1007/s13765‑016‑0150‑2
     [Google Scholar]
  93. SemwalD. SemwalR. CombrinckS. ViljoenA. Myricetin: A dietary molecule with diverse biological activities.Nutrients20168290010.3390/nu8020090 26891321
     [Google Scholar]
  94. ChanputW. KrueyosN. RitthiruangdejP. Anti-oxidative assays as markers for anti-inflammatory activity of flavonoids.Int. Immunopharmacol.20164017017510.1016/j.intimp.2016.08.038 27598863
     [Google Scholar]
  95. RamezaniM. DarbandiN. KhodagholiF. HashemiA. Myricetin protects hippocampal CA3 pyramidal neurons and improves learning and memory impairments in rats with Alzheimer’s disease.Neural Regen. Res.201611121976198010.4103/1673‑5374.197141 28197195
     [Google Scholar]
  96. MorenoL.C.G.I. PuertaE. Suárez-SantiagoJ.E. Santos-MagalhãesN.S. RamirezM.J. IracheJ.M. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease.Int. J. Pharm.20175171-2505710.1016/j.ijpharm.2016.11.061 27915007
     [Google Scholar]
  97. WangB. ZhongY. GaoC. LiJ. Myricetin ameliorates scopolamine-induced memory impairment in mice via inhibiting acetylcholinesterase and down-regulating brain iron.Biochem. Biophys. Res. Commun.2017490233634210.1016/j.bbrc.2017.06.045 28619513
     [Google Scholar]
  98. ChenH. LinH. XieS. Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination.Toxicol. Appl. Pharmacol.2019365192910.1016/j.taap.2018.12.019 30594691
     [Google Scholar]
  99. ZhuT. WangL. WangL.P. WanQ. Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs.Biomed. Pharmacother.202214811271910.1016/j.biopha.2022.112719
     [Google Scholar]
  100. DarbandiN. RamezaniM. KhodagholiF. NooriM. Kaempferol promotes memory retention and density of hippocampal CA1 neurons in intra-cerebroventricular STZ-induced experimental AD model in Wistar rats.Biologija20166210.6001/biologija.v62i3.3368
     [Google Scholar]
  101. PateK.M. RogersM. ReedJ.W. van der MunnikN. VanceS.Z. MossM.A. Anthoxanthin polyphenols attenuate A β oligomer‐induced neuronal responses associated with Alzheimer’s disease.CNS Neurosci. Ther.201723213514410.1111/cns.12659 27864869
     [Google Scholar]
  102. BegT. JyotiS. NazF. Protective effect of kaempferol on the transgenic drosophila model of Alzheimer’s disease.CNS Neurol. Disord. Drug Targets201817642142910.2174/1871527317666180508123050 29745345
     [Google Scholar]
  103. BabaeiP. KouhestaniS. JafariA. Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia.Neural Regen. Res.201813101827183210.4103/1673‑5374.238714 30136699
     [Google Scholar]
  104. KimJ.H. KimH.Y. ChoE.J. Protective effects of kaempferol, quercetin, and its glycosides on amyloid beta-induced neurotoxicity in C6 glial cell.J. Appl. Biol. Chem.201962432733210.3839/jabc.2019.045
     [Google Scholar]
  105. KilicF.S. KaygisizB. AydinS. YildirimE. OnerS. ErolK. The effects and mechanisms of the action of galangin on spatial memory in rats.Bratisl. Med. J.20191201288188610.4149/BLL_2019_148 31855045
     [Google Scholar]
  106. HuangL. LinM. ZhongX. YangH. DengM. Galangin decreases p tau, Aβ42 and β secretase levels, and suppresses autophagy in okadaic acid induced PC12 cells via an Akt/GSK3β/mTOR signaling dependent mechanism.Mol. Med. Rep.20191931767177410.3892/mmr.2019.9824 30628698
     [Google Scholar]
  107. ChandraS. RoyA. JanaM. PahanK. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model.Neurobiol. Dis.201912437939510.1016/j.nbd.2018.12.007 30578827
     [Google Scholar]
  108. El-HoranyH.E. El-latifR.N.A. ElBatshM.M. EmamM.N. Ameliorative effect of quercetin on neurochemical and behavioral deficits in rotenone rat model of Parkinson’s disease: Modulating autophagy (Quercetin on Experimental Parkinson’s Disease).J. Biochem. Mol. Toxicol.201630736036910.1002/jbt.21821 27252111
     [Google Scholar]
  109. AyM. LuoJ. LangleyM. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson’s disease.J. Neurochem.2017141576678210.1111/jnc.14033 28376279
     [Google Scholar]
  110. GhaffariF. Hajizadeh MoghaddamA. ZareM. Research paper: Neuroprotective effect of quercetin nanocrystal in a 6-hydroxydopamine model of Parkinson disease: Biochemical and behavioral evidence.Basic Clin. Neurosci.20189531732410.32598/bcn.9.5.317 30719246
     [Google Scholar]
  111. HuangB. LiuJ. MaD. ChenG. WangW. FuS. Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model.J. Funct. Foods20184545246110.1016/j.jff.2018.04.018
     [Google Scholar]
  112. GuoB. ZhengC. CaiW. Multifunction of chrysin in Parkinson’s model: Anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B.J. Agric. Food Chem.201664265324533310.1021/acs.jafc.6b01707 27245668
     [Google Scholar]
  113. AhmedM.R. ShaikhM.A. BalochN.A. NazirS. AbrarH. UlhaqH.S.I. Neuroprotective potential of polydatin against motor abnormalities and dopaminergic neuronal loss in rotenone induced parkinson model.Int. J. Morphol.201836258459110.4067/S0717‑95022018000200584
     [Google Scholar]
  114. JuvekarAR KhatriDK Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid.Pharmacogn Mag20161246116(Suppl. 2)10.4103/0973‑1296.18216827279695
     [Google Scholar]
  115. BaluchnejadmojaradT. RabieeN. ZabihnejadS. RoghaniM. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson’s disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.Brain Res.20171662233010.1016/j.brainres.2017.02.021 28238669
     [Google Scholar]
  116. ProrokT. JanaM. PatelD. PahanK. Cinnamic acid protects the nigrostriatum in a mouse model of Parkinson’s disease via peroxisome proliferator-activated receptorα.Neurochem. Res.201944475176210.1007/s11064‑018‑02705‑0 30612307
     [Google Scholar]
  117. JangJ.H. LeeS.H. JungK. YooH. ParkG. Inhibitory effects of myricetin on lipopolysaccharide-induced neuroinflammation.Brain Sci.20201013210.3390/brainsci10010032 31935983
     [Google Scholar]
  118. ChenQ.X. ZhouL. LongT. Galangin exhibits neuroprotective effects in 6-OHDA-induced models of Parkinson’s disease via the Nrf2/Keap1 pathway.Pharmaceuticals2022158101410.3390/ph15081014 36015161
     [Google Scholar]
  119. GuoH. YiJ. WangF. LeiT. DuH. Potential application of heat shock proteins as therapeutic targets in Parkinson’s disease.Neurochem. Int.202316210545310.1016/j.neuint.2022.105453 36402293
     [Google Scholar]
  120. GoyalA. AgrawalA. VermaA. DubeyN. The PI3K-AKT pathway: A plausible therapeutic target in Parkinson’s disease.Exp. Mol. Pathol.202312910484610.1016/j.yexmp.2022.104846 36436571
     [Google Scholar]
  121. SiddiqueY.H. JyotiS. Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson’s disease exposed to apigenin.Integr. Med. Res.20176324525310.1016/j.imr.2017.04.003 28951838
     [Google Scholar]
  122. SandhirR. MehrotraA. Quercetin supplementation is effective] in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: Implications in Huntington’s disease.Biochim. Biophys. Acta20131832342143010.1016/j.bbadis.2012.11.018 23220257
     [Google Scholar]
  123. ChakrabortyJ. SinghR. DuttaD. NaskarA. RajammaU. MohanakumarK.P. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington’s Disease.CNS Neurosci. Ther.2014201101910.1111/cns.12189 24188794
     [Google Scholar]
  124. JoshiV. MishraR. UpadhyayA. Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation.J. Cell. Physiol.201923411209002091410.1002/jcp.28695 31004355
     [Google Scholar]
  125. KhanE. TawaniA. MishraS.K. Myricetin reduces toxic level of CAG repeats RNA in Huntington’s disease (HD) and spino cerebellar ataxia (SCAs).ACS Chem. Biol.201813118018810.1021/acschembio.7b00699 29172480
     [Google Scholar]
  126. ThangarajanS. RamachandranS. KrishnamurthyP. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair—Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax—Bad genes in male wistar rats.Biomed. Pharmacother.20168451452510.1016/j.biopha.2016.09.070 27690136
     [Google Scholar]
  127. HaiderM. SalmanM. KaushikP. Chrysin ameliorates 3 nitropropinoic acid induced neurotoxicity targeting behavioural, biochemical and histological alterations.Int. J. Neurosci.2022132545045810.1080/00207454.2020.1821677 32901525
     [Google Scholar]
  128. JoneidiS. AlizadehS.R. EbrahimzadehM.A. Chlorogenic acid derivatives: Structural modifications, drug design, and biological activities: A review.Mini Rev. Med. Chem.202424774876610.2174/1389557523666230822095959 37608658
     [Google Scholar]
  129. BhatiaN.K. ModiP. SharmaS. DeepS. Quercetin and baicalein act as potent antiamyloidogenic and fibril destabilizing Agents for SOD1 fibrils.ACS Chem. Neurosci.20201181129113810.1021/acschemneuro.9b00677 32208672
     [Google Scholar]
  130. Noorbakhsh VarnosfaderaniS.M. Sadat HaeriM. ArianA.S. Yousefi RadA. YazdanpourM. MojahedianF. Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: A computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation.J. Biomol. Struct. Dyn.202343141943610.1080/07391102.2023.2281641 37975411
     [Google Scholar]
  131. UedaT. IndenM. KiuchiM. AsakaY. KuritaH. HozumiI. The effects of kaempferol against mutant copper-zinc superoxide dismutase-mediated toxicity via autophagy.Proc Annu Meet Jpn Pharmacol Soc2018WCP2018PO38–410.1254/jpssuppl.wcp2018.0_po3‑8‑4
     [Google Scholar]
  132. UedaT. ItoT. KuritaH. IndenM. HozumiI. p-coumaric acid has protective effects against mutant copper-zinc superoxide dismutase 1 via the activation of autophagy in N2a cells.Int. J. Mol. Sci.20192012294210.3390/ijms20122942 31208129
     [Google Scholar]
  133. AaronC. BeaudryG. ParkerJ.A. TherrienM. Maple syrup decreases TDP-43 proteotoxicity in a Caenorhabditis elegans model of amyotrophic lateral sclerosis (ALS).J. Agric. Food Chem.201664173338334410.1021/acs.jafc.5b05432 27071850
     [Google Scholar]
  134. MayaS. PrakashT. GoliD. Evaluation of neuroprotective effects of wedelolactone and gallic acid on aluminium-induced neurodegeneration: Relevance to sporadic amyotrophic lateral sclerosis.Eur. J. Pharmacol.2018835415110.1016/j.ejphar.2018.07.058 30075221
     [Google Scholar]
  135. SM. TP. GoliD. Effect of wedelolactone and gallic acid on quinolinic acid-induced neurotoxicity and impaired motor function: Significance to sporadic amyotrophic lateral sclerosis.Neurotoxicology20186811210.1016/j.neuro.2018.06.015 29981346
     [Google Scholar]
  136. Nassiri-AslM. MoghbelinejadS. RashvandZ. KhodabandehlooF. MohammadiG. Modulation of the expression of the GABAA receptor β1 and β3 subunits by pretreatment with quercetin in the KA model of epilepsy in mice.J. Pharmacopuncture201619216316610.3831/KPI.2016.19.018 27386150
     [Google Scholar]
  137. HashemianM. Ghasemi-KasmanM. GhasemiS. Fabrication and evaluation of novel quercetin-conjugated Fe3O4-β-cyclodextrin nanoparticles for potential use in epilepsy disorder.Int. J. Nanomedicine2019146481649510.2147/IJN.S218317 31496698
     [Google Scholar]
  138. WuD. ZhengZ. FanS. Ameliorating effect of quercetin on epilepsy by inhibition of inflammation in glial cells.Exp. Ther. Med.202020285485910.3892/etm.2020.8742 32742328
     [Google Scholar]
  139. PrakashC. TyagiJ. RabidasS.S. KumarV. SharmaD. Therapeutic potential of quercetin and its derivatives in epilepsy: Evidence from preclinical studies.Neuromolecular Med.202325216317810.1007/s12017‑022‑08724‑z 35951285
     [Google Scholar]
  140. HeX. ChenX. YangY. XieY. LiuY. Medicinal plants for epileptic seizures: Phytoconstituents, pharmacology and mechanisms revisited.J. Ethnopharmacol.202432011738610.1016/j.jep.2023.117386 37956914
     [Google Scholar]
  141. XiangJ. JiangY. Antiepileptic potential of matrine via regulation the levels of gamma-aminobutyric acid and glutamic acid in the brain.Int. J. Mol. Sci.20131412237512376110.3390/ijms141223751 24317434
     [Google Scholar]
  142. SunZ.Q. MengF.H. TuL.X. SunL. Myricetin attenuates the severity of seizures and neuroapoptosis in pentylenetetrazole kindled mice by regulating the of BDNF TrkB signaling pathway and modulating matrix metalloproteinase 9 and GABAA.Exp. Ther. Med.20191743083309110.3892/etm.2019.7282 30906480
     [Google Scholar]
  143. ZhenJL ChangYN QuZZ FuT LiuJQ WangWP Luteolin rescues pentylenetetrazole-induced cognitive impairment in epileptic rats by reducing oxidative stress and activating PKA/CREB/BDNF signaling.Epilepsy Behav201657Pt A1778410.1016/j.yebeh.2016.02.00126967006
     [Google Scholar]
  144. MyoH. LianaD. PhanumartwiwathA. Unlocking therapeutic potential: Comprehensive extraction, profiling, and pharmacological evaluation of bioactive compounds from Eclipta alba (L.) Hassk. for dermatological applications.Plants20231313310.3390/plants13010033 38202343
     [Google Scholar]
  145. SharmaP. KumariA. GulatiA. KrishnamurthyS. HemalathaS. Chrysin isolated from Pyrus pashia fruit ameliorates convulsions in experimental animals.Nutr. Neurosci.201922856957710.1080/1028415X.2017.1418786 29284373
     [Google Scholar]
  146. ZhangY. ZhaoJ. AfzalO. Neuroprotective role of chrysin‐loaded poly(lactic‐co‐glycolic acid) nanoparticle against kindling‐induced epilepsy through Nrf2/ARE/HO‐1 pathway.J. Biochem. Mol. Toxicol.2021352e2263410.1002/jbt.22634 32991785
     [Google Scholar]
  147. ZhangY. SeeburgD.P. PulliB. Myeloperoxidase nuclear imaging for epileptogenesis.Radiology2016278382283010.1148/radiol.2015141922 26397127
     [Google Scholar]
  148. SharmaP. SharmaS. SinghD. Apigenin reverses behavioural impairments and cognitive decline in kindled mice via CREB-BDNF upregulation in the hippocampus.Nutr. Neurosci.202023211812710.1080/1028415X.2018.1478653 29847220
     [Google Scholar]
  149. ShaoC. YuanJ. LiuY. Epileptic brain fluorescent imaging reveals apigenin can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis.Proc. Natl. Acad. Sci. USA202011719101551016410.1073/pnas.1917946117 32327603
     [Google Scholar]
  150. HassanzadehP. ArbabiE. AtyabiF. DinarvandR. Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy.Life Sci.201717991410.1016/j.lfs.2016.08.011 27534908
     [Google Scholar]
  151. HusseinA.M. AbbasK.M. AbulseoudO.A. El-HussainyE.H.M.A. Effects of ferulic acid on oxidative stress, heat shock protein 70, connexin 43, and monoamines in the hippocampus of pentylenetetrazole-kindled rats.Can. J. Physiol. Pharmacol.201795673274210.1139/cjpp‑2016‑0219 28177659
     [Google Scholar]
  152. SinghT. KaurT. GoelR.K. Ferulic acid supplementation for management of depression in epilepsy.Neurochem. Res.201742102940294810.1007/s11064‑017‑2325‑6 28608235
     [Google Scholar]
  153. KhodayarM.J. SalehiS. RezaeiM. SiahpooshA. KhazaeiA. HoushmandG. Evaluation of the effect of naringenin on pentylenetetrazole and maximal electroshock-induced convulsions in mice.Jundishapur J. Nat. Pharm. Prod.201612110.5812/jjnpp.31384
     [Google Scholar]
  154. ParkJ. JeongK.H. ShinW.H. BaeY.S. JungU.J. KimS.R. Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy.Neuroreport201627151182118910.1097/WNR.0000000000000678 27584687
     [Google Scholar]
  155. TabassumN ShakeelS RehmanMU AminU MirMR Effect of naringenin (A naturally occurring flavanone) against pilocarpineinduced status epilepticus and oxidative stress in mice.Pharmacogn Mag20171349154(Suppl. 1)10.4103/0973‑1296.20397728479741
     [Google Scholar]
  156. MertD.G. TurgutN.H. ArslanbasE. GungorH. KaraH. The influence of quercetin on recognition memory and brain oxidative damage in a ketamine model of schizophrenia.Psychiatry Clin Psychopharmacol20192911710.1080/24750573.2018.1442670
     [Google Scholar]
  157. AgrawalK. ChakrabortyP. DewanjeeS. Neuropharmacological interventions of quercetin and its derivatives in neurological and psychological disorders.Neurosci. Biobehav. Rev.202314410495510.1016/j.neubiorev.2022.104955 36395983
     [Google Scholar]
  158. KhanK. NajmiA.K. AkhtarM. A Natural phenolic compound quercetin showed the usefulness by targeting inflammatory, oxidative stress markers and augment 5-HT levels in one of the animal models of depression in mice.Drug Res.201969739240010.1055/a‑0748‑5518 30296804
     [Google Scholar]
  159. SamadN. SaleemA. YasminF. ShehzadM.A. Quercetin protects against stress-induced anxiety- and depression-like behavior and improves memory in male mice.Physiol. Res.201879580810.33549/physiolres.933776
     [Google Scholar]
  160. FangK. LiH.R. ChenX.X. Quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of copine 6 and TREM1/2 in the hippocampus and PFC.Front. Pharmacol.2020101544410.3389/fphar.2019.01544 32009956
     [Google Scholar]
  161. SurB. LeeB. Myricetin inhibited fear and anxiety-like behaviors by HPA axis regulation and activation of the BDNF-ERK signaling pathway in posttraumatic stress disorder rats.Evid. Based Complement. Alternat. Med.20222022111110.1155/2022/8320256 35722162
     [Google Scholar]
  162. GaoW. WangW. PengY. DengZ. Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT/β-catenin cascade.Metab. Brain Dis.201934248549410.1007/s11011‑019‑0389‑5 30762138
     [Google Scholar]
  163. FilhoC.B. JesseC.R. DonatoF. Chronic unpredictable mild stress decreases BDNF and NGF levels and Na+,K+-ATPase activity in the hippocampus and prefrontal cortex of mice: Antidepressant effect of chrysin.Neuroscience201528936738010.1016/j.neuroscience.2014.12.048 25592430
     [Google Scholar]
  164. Abd Al HaleemE.N. AhmedH.I. El-NagaR.N. Lycopene and chrysin through mitigation of neuroinflammation and oxidative stress exerted antidepressant effects in clonidine-induced depression-like behavior in rats.J. Diet. Suppl.202320339141010.1080/19390211.2021.1988797 34633271
     [Google Scholar]
  165. BansalY. SinghR. SarojP. SodhiR.K. KuhadA. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.Toxicol. Appl. Pharmacol.201835525726810.1016/j.taap.2018.07.010 30017640
     [Google Scholar]
  166. UmukoroS. KalejayeH.A. Ben-AzuB. AjayiA.M. Naringenin attenuates behavioral derangements induced by social defeat stress in mice via inhibition of acetylcholinesterase activity, oxidative stress and release of pro-inflammatory cytokines.Biomed. Pharmacother.201810571472310.1016/j.biopha.2018.06.016 29906750
     [Google Scholar]
  167. TayyabM. FarheenS. MM.M.P. KhanamN. Mobarak HossainM. ShahiM.H. Antidepressant and neuroprotective effects of naringenin via sonic hedgehog-GLI1 cell signaling pathway in a rat model of chronic unpredictable mild stress.Neuromolecular Med.201921325026110.1007/s12017‑019‑08538‑6 31037465
     [Google Scholar]
  168. LeeS. KimH.B. HwangE.S. Antidepressant-like effects of p-coumaric acid on LPS-induced depressive and inflammatory changes in rats.Exp. Neurobiol.201827318919910.5607/en.2018.27.3.189 30022870
     [Google Scholar]
  169. ZhengX. ChengY. ChenY. Ferulic acid improves depressive-like behavior in prenatally-stressed offspring rats via anti-inflammatory activity and HPA axis.Int. J. Mol. Sci.201920349310.3390/ijms20030493 30678337
     [Google Scholar]
  170. HeL. BoX.M. YuR.B. DuS.J. ZhangR.L. Ferulic acid alleviates lipopolysaccharide-induced depression-like behavior by inhibiting inflammation and apoptosis.Asian Pac. J. Trop. Biomed.2020101252310.4103/2221‑1691.297051
     [Google Scholar]
  171. MărgăoanR. TopalE. BalkanskaR. Monofloral honeys as a potential source of natural antioxidants, minerals and medicine.Antioxidants2021107102310.3390/antiox10071023 34202118
     [Google Scholar]
  172. MishraSarita ByadgiP.S. Proper digestion as a regulator of female reproductive physiology- An Ayurvedic perspective.Int J Res Pharm Sci20191032199220810.26452/ijrps.v10i3.1452
     [Google Scholar]
  173. OthmanZ. ShafinN. ZakariaR. HussainN.H.N. MohammadW.M.Z.W. Improvement in immediate memory after 16 weeks of tualang honey (Agro Mas) supplement in healthy postmenopausal women.Menopause201118111219122410.1097/gme.0b013e31821e2044 21926932
     [Google Scholar]
  174. ChepulisL.M. StarkeyN.J. WaasJ.R. MolanP.C. The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats.Physiol. Behav.2009973-435936810.1016/j.physbeh.2009.03.001 19296910
     [Google Scholar]
  175. HarmanD. Aging: A theory based on free radical and radiation chemistry.J. Gerontol.195611329830010.1093/geronj/11.3.298 13332224
     [Google Scholar]
  176. MarianiE. PolidoriM.C. CherubiniA. MecocciP. Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.20058271657510.1016/j.jchromb.2005.04.023 16183338
     [Google Scholar]
  177. OyekunleO.A. OgundejiT.P. OkojieA.K. Behavioral modifications related to consumption of a “Soft” adaptogen, bee honey, by rats.Neurophysiology2011431384110.1007/s11062‑011‑9183‑7
     [Google Scholar]
  178. AkanmuM.A. OlowookereT.A. AtunwaS.A. Neuropharmacological effects of Nigerian honey in mice.Afr. J. Tradit. Complement. Altern. Med.20118323024910.4314/ajtcam.v8i3.65285 22468002
     [Google Scholar]
  179. LampreaM.R. CardenasF.P. SilveiraR. WalshT.J. MoratoS. Effects of septal cholinergic lesion on rat exploratory behavior in an open-field.Braz. J. Med. Biol. Res.200336223323810.1590/S0100‑879X2003000200011 12563526
     [Google Scholar]
  180. PatelJ.C. RossignolE. RiceM.E. MacholdR.P. Opposing regulation of dopaminergic activity and exploratory motor behavior by forebrain and brainstem cholinergic circuits.Nat. Commun.2012311172210.1038/ncomms2144 23132022
     [Google Scholar]
  181. CarneiroI.B.C. ToscanoA.E. LacerdaD.C. L-tryptophan administration and increase in cerebral serotonin levels: Systematic review.Eur. J. Pharmacol.201883612913510.1016/j.ejphar.2018.08.009 30098308
     [Google Scholar]
  182. Frank-CannonT.C. AltoL.T. McAlpineF.E. TanseyM.G. Does neuroinflammation fan the flame in neurodegenerative diseases?Mol. Neurodegener.20094147710.1186/1750‑1326‑4‑47 19917131
     [Google Scholar]
  183. CarsonM.J. Cameron ThrashJ. WalterB. The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival.Clin. Neurosci. Res.20066523724510.1016/j.cnr.2006.09.004 19169437
     [Google Scholar]
  184. ErejuwaO. SulaimanS. WahabM. Effects of honey and its mechanisms of action on the development and progression of cancer.Molecules20141922497252210.3390/molecules19022497 24566317
     [Google Scholar]
  185. HeoG. KangD. ParkC. Pro apoptotic effect of the novel benzylidene derivative MHY695 in human colon cancer cells.Oncol. Lett.20191833256326410.3892/ol.2019.10664 31452803
     [Google Scholar]
  186. RannehY. AkimA.M. HamidH.A. Honey and its nutritional and anti-inflammatory value.BMC Complement Med Ther202121130010.1186/s12906‑020‑03170‑5 33441127
     [Google Scholar]
  187. MartinS.J. GrimwoodP.D. MorrisR.G.M. Synaptic plasticity and memory: An evaluation of the hypothesis.Annu. Rev. Neurosci.200023164971110.1146/annurev.neuro.23.1.649 10845078
     [Google Scholar]
  188. BaudryM. ZhuG. LiuY. WangY. BrizV. BiX. Multiple cellular cascades participate in long-term potentiation and in hippocampus-dependent learning.Brain Res.20151621738110.1016/j.brainres.2014.11.033 25482663
     [Google Scholar]
  189. NicollR.A. MalenkaR.C. Contrasting properties of two forms of long-term potentiation in the hippocampus.Nature1995377654511511810.1038/377115a0 7675078
     [Google Scholar]
  190. VoglisG. TavernarakisN. The role of synaptic ion channels in synaptic plasticity.EMBO Rep.20067111104111010.1038/sj.embor.7400830 17077866
     [Google Scholar]
  191. BlissT.V.P. CollingridgeG.L. MorrisR.G.M. ReymannK.G. Long-term potentiation in the hippocampus: Discovery, mechanisms and function.Neuroforum2018243A103A12010.1515/nf‑2017‑A059
     [Google Scholar]
  192. BradshawK.D. EmptageN.J. BlissT.V.P. A role for dendritic protein synthesis in hippocampal late LTP.Eur. J. Neurosci.200318113150315210.1111/j.1460‑9568.2003.03054.x 14656312
     [Google Scholar]
  193. SwankM.W. SweattJ.D. Increased histone acetyltransferase and lysine acetyltransferase activity and biphasic activation of the ERK/RSK cascade in insular cortex during novel taste learning.J. Neurosci.200121103383339110.1523/JNEUROSCI.21‑10‑03383.2001 11331368
     [Google Scholar]
  194. KimS. KimH. UmJ.W. Synapse development organized by neuronal activity-regulated immediate-early genes.Exp. Mol. Med.20185041710.1038/s12276‑018‑0061‑x 29628504
     [Google Scholar]
  195. MeftahK. MeftahS. LamkhanterH. Extraction and optimization of Austrocylindropuntia subulata powder as a novel green coagulant.Desalination Water Treat.202431810033910.1016/j.dwt.2024.100339
     [Google Scholar]
  196. NaboulsiA. BouzidT. GrichA. RegtiA. El HimriM. El HaddadM. Understanding the column and batch adsorption mechanism of pesticide 2,4,5-T utilizing alginate-biomass hydrogel capsule: A computational and economic investigation.Int. J. Biol. Macromol.2024275Pt 213376210.1016/j.ijbiomac.2024.133762 38986974
     [Google Scholar]
  197. RepiciM. MarianiJ. BorselloT. Neuronal death and neuroprotection: A review.Methods Mol. Biol.200739911410.1007/978‑1‑59745‑504‑6_1 18309921
     [Google Scholar]
  198. FangY. ShaoA. HuangL. ZhangX. HermannD.M. Editorial: Crosstalk between peripheral and local immune response in the pathophysiology of stroke and neurodegeneration diseases, volume II.Front. Cell. Neurosci.2024181384276610.3389/fncel.2024.1384276 38481631
     [Google Scholar]
  199. RameshV. SubbarayanK. ViswanathanS. SubramanianK. Role of nutraceuticals in the management of lifestyle diseases. In: Role of Herbal Medicines.SingaporeSpringer202346147810.1007/978‑981‑99‑7703‑1_23
     [Google Scholar]
  200. LiC. WuX. LiuS. ShenD. ZhuJ. LiuK. Role of resolvins in the inflammatory resolution of neurological diseases.Front. Pharmacol.20201161210.3389/fphar.2020.00612 32457616
     [Google Scholar]
  201. BhartiS.K. ShuklaD. MahapatraD.K. AsatiV. KeservaniR.K. Therapeutic potential of nutraceuticals for the management of neurodegenerative disorders. In: Nutraceutical Fruits and Foods for Neurodegenerative Disorders.Academic Press202452553510.1016/B978‑0‑443‑18951‑7.00028‑1
     [Google Scholar]
  202. PengX. ZhangX. SharmaG. DaiC. Thymol as a potential neuroprotective agent: Mechanisms, efficacy, and future prospects.J. Agric. Food Chem.202472136803681410.1021/acs.jafc.3c06461 38507708
     [Google Scholar]
  203. RajiniP.S. Indian spices and their bioactives in neurological disorders. In: Ayurvedic Herbal Preparations in Neurological Disorders.Academic Press202354157510.1016/B978‑0‑443‑19084‑1.00018‑1
     [Google Scholar]
  204. MattsonM.P. LeakR.K. The hormesis principle of neuroplasticity and neuroprotection.Cell Metab.202436231533710.1016/j.cmet.2023.12.022 38211591
     [Google Scholar]
  205. ShatiA.A. ElsaidF.G. HafezE.E. Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of Crocus sativus L. extraction and honey syrup.Neuroscience2011175667410.1016/j.neuroscience.2010.11.043 21115102
     [Google Scholar]
  206. SaxenaA.K. PhyuH.P. Al-AniI.M. TalibN.A. Potential protective effect of honey against chronic cerebral hypoperfusion-induced neurodegeneration in rats.J. Anat. Soc. India201463215115510.1016/j.jasi.2014.11.003
     [Google Scholar]
  207. BirksJ.S. Cholinesterase inhibitors for Alzheimer’s disease.Cochrane Libr.200620163CD00559310.1002/14651858.CD005593 16437532
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128383966250726122514
Loading
Neuro-protective Potential of Honey: A Narrative Review
Curr. Pharm. Des. 32, 901 (2026); https://doi.org/10.2174/0113816128383966250726122514
/content/journals/cpd/10.2174/0113816128383966250726122514
/content/journals/cpd/10.2174/0113816128383966250726122514
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): antioxidants; apitherapeutics; Honey; neurological disorders; oxidative stress; polyphenols

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test